about
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia5-HT6 receptors and Alzheimer's diseaseDirect interaction and functional coupling between human 5-HT6 receptor and the light chain 1 subunit of the microtubule-associated protein 1B (MAP1B-LC1)AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsEffect of acute and chronic electroconvulsive shock on 5-hydroxytrypamine 6 receptor immunoreactivity in rat hippocampus.The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms.Serotonin and molecular neuroimaging in humans using PET.The serotonin-6 receptor as a novel therapeutic target.5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivatives.Novel disease-modifying therapeutics for the treatment of Alzheimer's disease.Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.Emerging drugs for schizophrenia: an update.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.5-HT6 receptor blockade regulates primary cilia morphology in striatal neurons.Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.Emerging amyloid and tau targeting treatments for Alzheimer's disease.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.A new serotonin 5-HT6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding.Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.Remote C-H Activation of Quinolines through Copper-Catalyzed Radical Cross-Coupling.[The mTOR pathway: a new target for treating cognitive deficits of schizophrenia?].Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease.
P2860
Q24299992-0AC085C3-0E3C-4C2B-94F7-42894660285FQ27006820-B606E86A-9B41-4031-8412-79E4D5FD5CDEQ28540701-726E868B-B686-475C-8E01-DC5924DC4698Q30377178-2E6AC3F0-E717-485D-B6B3-FBA3079DFEBEQ30486707-C50D1A98-F8A9-4C8F-9CC0-124FD78CB1F0Q34241575-248B7CC5-E76D-4267-9FF2-7B16ACE20A19Q34335586-ECBDD01E-99D3-47BA-9FB6-4C2CE379CF4EQ34653803-72A0B0EB-D0A6-4945-80AA-A9754BB5F839Q36057491-FAAAF5AC-4553-4643-8D4A-FA75014B23D6Q36346938-06BB2571-69F0-4C7C-9814-CE4824972A44Q37938794-4BF1556C-3683-423B-8E7F-CED17C116485Q37987116-61328E01-7EC5-4292-9A48-C307AE048A86Q38027891-CCD74D8C-131A-4A52-B620-B4FA1B4453EAQ38127470-89E73792-2773-4073-A84E-57F9BF7A6437Q38149953-C1F25903-B553-4BBC-9F55-EC6D6AE722CFQ38209851-04DF2985-D2AB-4854-982D-EDD09588271AQ38252404-9473F45D-FEF5-44C2-A6E1-B71B29C2B6EEQ38286222-7CB96AF3-D9F1-4CF6-B964-85580B3C40EFQ38298300-E88F2944-2F75-47C3-B6DD-813C8075AB7AQ39021418-C8C578E1-6F38-4B85-BE71-CBB08F13861BQ39134334-2FC1D112-F2F9-4AA1-902F-4588B6DDD9D9Q39296311-A03938B1-98F5-49AB-A93D-7F8AC5A28758Q39296351-25858300-30DF-4692-B393-BD031FC097DCQ42328355-806D9751-041F-45B3-824A-82B00ADAAA4CQ47294212-3ABA8CE2-A524-4D88-B5FA-A16117CF6F04Q48264441-8F365EFA-A918-4D32-8AD9-3951343CEB5EQ54454032-2D4A08EC-2DB7-4C5F-9A72-ACA619DF8206Q55297754-69D89DD0-FB8B-45D7-B03B-4C6E9BD88D58
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
5-HT(6) receptor and cognition.
@ast
5-HT(6) receptor and cognition.
@en
type
label
5-HT(6) receptor and cognition.
@ast
5-HT(6) receptor and cognition.
@en
prefLabel
5-HT(6) receptor and cognition.
@ast
5-HT(6) receptor and cognition.
@en
P1476
5-HT(6) receptor and cognition.
@en
P2093
Jose Miguel Vela
Xabier Codony
P304
P356
10.1016/J.COPH.2011.01.004
P577
2011-02-15T00:00:00Z